Malgorzata (Gosia) Jaremko, PhD, MBA, FACMG, FACB, MB(ASCP), MSc, Eng

Malgorzata (Gosia) Jaremko, PhD, MBA, FACMG, FACB, MB(ASCP), MSc, Eng is an accomplished professional with a diverse work experience in the field of genomics and genetics. Malgorzata (Gosia) Jaremko, is the Founder & CEO, President of Gosia Genomics, a company they started in 2022. Prior to that, they served as the Chief Laboratory Officer & Medical Director at Genetika+ starting from 2022. Malgorzata (Gosia) Jaremko, also worked as a Genetics Lab Director Consultant at Enzo Clinical Labs in 2022 and as a Genomics Laboratory Director at New Hope Fertility Center from 2018 onwards.

Additionally, Jaremko has been an Independent Clinical Genetics Consultant at Kindbody (2022), a Health Wildcatters Accelerator Alumni at Health Wildcatters (2022), and a Co-Founder & Sr Executive Vice President, Clinical Lab & Molecular Diagnostics, CLIA-Lab Director at Phosphorus (2016-2022). Malgorzata (Gosia) Jaremko, has also held positions such as CLIA Laboratory Director, Infectious Diseases at Wheeler Labs (2020-2021) and CLIA Laboratory Director at Genomic Prediction (2018).

Earlier in their career, Jaremko worked at Athena Diagnostics, Quest Diagnostics Inc., where they held roles including Senior Director, Genetics (2013-2016), Director, Genetics (2011-2013), and Associate Director, Genetics (2010-2011).

With their extensive background and expertise, Jaremko has made significant contributions in the field of genomics and genetics throughout their career.

Malgorzata (Gosia) Jaremko, PhD, MBA, FACMG, FACB, MB(ASCP), MSc, Eng has an extensive education history spanning various fields of study.

Malgorzata (Gosia) Jaremko, obtained a Master of Engineering (MEng) degree and a Master of Science (MSc) from Wroclaw University of Science and Technology in an unspecified year. Following this, they pursued a Doctor of Philosophy (PhD) in Molecular Biology from Wroclaw Medical University, completing their studies in an unspecified year as well.

Additionally, Malgorzata obtained postgraduate degrees in Journalism from the Papal Faculty of Theology, Wroclaw University, and in Molecular Medicine from the Medical University of Warsaw (MUW) in 2007.

Malgorzata (Gosia) Jaremko, continued their education with clinical fellowships in Clinical Molecular & Biochemical Genetics from Icahn School of Medicine at Mount Sinai, completed in 2010, and in Clinical Cytogenetics from Texas Tech University, to be completed in 2022.

Malgorzata has also attained several certifications in their field. In 2011, they became certified by the American Board of Medical Genetics and Genomics in Clinical Biochemical Genetics and Clinical Molecular Genetics. In the same year, they were honored as a Fellow of the American College of Medical Genetics & Genomics (ACMG).

In 2012, they obtained the prestigious title of Fellow of the National Academy of Clinical Biochemistry from the National Academy of Clinical Biochemistry.